EV/EBITDA:
-8.62+0.38(+4.22%)Summary
- As of today, TSHA EV/EBITDA is -8.62, with a rise of +0.38 (+4.22%) during the most recent trading session on November 19, 2025.
- Over the past year, TSHA EV/EBITDA has dropped by -4.45 (-106.71%).
- TSHA EV/EBITDA is now -7736.36% below its all-time high of -0.11.
Performance
TSHA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TSHA EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +4.2% | -4.2% | -3.4% |
| 1M1 Month | +18.2% | -18.3% | -15.0% |
| 3M3 Months | -45.4% | +66.8% | +41.2% |
| 6M6 Months | -30.8% | +60.0% | +43.7% |
| YTDYTD | -163.6% | +211.9% | +131.8% |
| 1Y1 Year | -106.7% | +156.8% | +89.2% |
| 5Y5 Years | +64.9% | +63.2% | -81.3% |
TSHA EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -8.13 | -6.0% | -11.71 | +26.4% |
| 3M | 3-Month | -5.90 | -46.1% | -12.22 | +29.5% |
| 6M | 6-Month | -4.28 | -101.4% | -12.22 | +29.5% |
| 1Y | 1-Year | -2.14 | -302.8% | -12.22 | +29.5% |
| 3Y | 3-Year | -0.11 | -7736.4% | -12.22 | +29.5% |
| 5Y | 5-Year | -0.11 | -7736.4% | -26.47 | +67.4% |
| All-Time | All-Time | -0.11 | -7736.4% | -26.47 | +67.4% |
TSHA EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -8.62(-163.6%) |
| 2024 | -3.27(+8.4%) |
| 2023 | -3.57(-275.8%) |
| Date | Value |
|---|---|
| 2022 | -0.95(+54.8%) |
| 2021 | -2.10(+89.1%) |
| 2020 | -19.26 |
FAQ
- What is Taysha Gene Therapies, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Taysha Gene Therapies, Inc.?
- What is TSHA EV/EBITDA year-to-date change?
- What is Taysha Gene Therapies, Inc. EV/EBITDA year-on-year change?
What is Taysha Gene Therapies, Inc. EV/EBITDA?
The current EV/EBITDA of TSHA is -8.62
What is the all-time high EV/EBITDA for Taysha Gene Therapies, Inc.?
Taysha Gene Therapies, Inc. all-time high EV/EBITDA is -0.11
What is TSHA EV/EBITDA year-to-date change?
Taysha Gene Therapies, Inc. EV/EBITDA has changed by -5.35 (-163.61%) since the beginning of the year
What is Taysha Gene Therapies, Inc. EV/EBITDA year-on-year change?
Over the past year, TSHA EV/EBITDA has changed by -4.45 (-106.71%)